摘要
目的:在分析各自研究中揭示AD怀疑的潜在后果的基础上,运用研究伦理原则的非危险性,本文的作者认为,研究早期AD检测的益处大于风险只有在有症状的人积极寻求支持的情况下进行研究,才会产生潜在的不良影响因为他们利用记忆诊所的服务。 结论:在没有症状的志愿者中,风险效益评估的结果似乎不太明显。鉴于披露的结果至少在最初可能会造成严重的痛苦和伤害,并考虑到研究检查产生假阳性结果的风险显着增加,我们建议使用研究伦理的“谨慎原则”支持第二组潜在研究参与者的限制性披露政策。对AD研究中公开结果的益处的不同观点反映在建立结果过程回报的建议中。
关键词: 阿尔茨海默病,早期诊断,轻度认知障碍,披露困境,研究伦理,风险效益评估。
Current Alzheimer Research
Title:The Ambivalence of Early Diagnosis – Returning Results in Current Alzheimer Research
Volume: 15 Issue: 1
关键词: 阿尔茨海默病,早期诊断,轻度认知障碍,披露困境,研究伦理,风险效益评估。
摘要: Objectives: Based on an analysis of the potential consequences of disclosing AD suspicions from respective research and using the research ethical principle of non-maleficence, the authors of this paper argue for the thesis that the benefits of early AD detection in research outweigh the risk of potential adverse effects only in cases where studies are conducted with symptomatic people actively seeking for support, e.g. as they utilize the services of memory clinics.
Conclusion: In the case of non-symptomatic volunteers, the result of the risk-benefit-assessment seems to be less distinctive. Given that disclosing results can, at least initially, cause severe distress and harm and taking into account that research examinations have a significantly increased risk of producing false-positive findings, we suggest to make use of a research-ethical “princple of caution” that supports a restrictive disclosure policy for the second group of potential study participants. This differentiated view on the benefits of disclosed findings in AD research is reflected in recommendations for the set-up of return of result processes.
Export Options
About this article
Cite this article as:
The Ambivalence of Early Diagnosis – Returning Results in Current Alzheimer Research, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/1567205014666170908101237
DOI https://dx.doi.org/10.2174/1567205014666170908101237 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perioperative Considerations in Rheumatoid Arthritis Patients
Current Rheumatology Reviews Receptor Fragments: Intracellular Signaling and Novel Therapeutic Targets
Current Hypertension Reviews TREM2 p.H157Y Variant and the Risk of Alzheimer’s Disease: A Meta-Analysis Involving 14,510 Subjects
Current Neurovascular Research 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
CNS & Neurological Disorders - Drug Targets Dipyridamole: A Drug with Unrecognized Antioxidant Activity
Current Topics in Medicinal Chemistry Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies
Vascular Disease Prevention (Discontinued) Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Current Medicinal Chemistry Serotonin (5-HT) in the Regulation of Depression-Related Emotionality: Insight from 5-HT Transporter and Tryptophan Hydroxylase-2 Knockout Mouse Models
Current Drug Targets Association of Cerebrospinal Fluid Adiponectin Levels With Cerebral Glucose Metabolism In Mild Cognitive Impairment: A Pilot Study
Current Alzheimer Research Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research The Multifunctional Mesencephalic Locomotor Region
Current Pharmaceutical Design Preface
Current Enzyme Inhibition Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Leukotrienes and Atherosclerosis
Current Drug Targets Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Current Neuropharmacology Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Lipids as Key Players in Alzheimer Disease - Alterations in Metabolism and Genetics
Current Alzheimer Research The Evolution of Histamine H3 Antagonists/Inverse Agonists
Current Topics in Medicinal Chemistry